Co-administration of 20(S)-protopanaxatriol (g-PPT) and EGFR-TKI overcomes EGFR-TKI resistance by decreasing SCD1 induced lipid accumulation in non-small cell lung cancer

Quanfu Huang(Union Hospital), Yongde Liao(Union Hospital)
Journal of Experimental & Clinical Cancer Research
March 15, 2019
Cited by 85


Related Papers